ENNIS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ENNIS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	357	370	401	438	358	400	432	420	395	392
Cost of revenue	252	253	277	309	254	285	301	295	277	272
Gross profit	105	117	123	129	104	115	131	125	117	120
Selling, general and administrative	62.5	69.2	73.5	78.2	68.3	71.4	70.8	68.8	65.4	67.7
Operating income	41.9	47.8	50.1	50.8	35.9	43.6	66.2	56.5	52	52.7
Interest expense	0.61	0.78	1.15	0.61	0.01	0.01	-0.77	-3.97
Interest income							0.77	3.97	4.87	1.89
Other non-operating income	-1.88	-0.91	-0.15	0.41	-2.61	-1.64	-1.22	2.66	3.48	5.9
Pre-tax income	40	46.9	49.9	51.3	33.3	41.9	64.9	59.1	55.5	58.6
Income tax	13.6	14.2	12.5	13	9.19	13	17.6	16.5	15.2	16
Net income	1.78	32.9	37.4	38.3	24.1	29	47.3	42.6	40.2	42.6
EBITDA	49.8	55.9	59.2	61.3	45.8	54	76.3	66.3	60.8	61.7
EPS, basic	0.07	1.30	1.45	1.47	0.93	1.11	1.83	1.65	1.55	1.66
EPS, diluted	0.07	1.30	1.45	1.47	0.93	1.11	1.82	1.64	1.54	1.66
Shares, basic (weighted)	25.7	25.4	25.8	26	26	26	25.8	25.8	26	25.6
Shares, diluted (weighted)	25.7	25.4	25.8	26	26	26.1	26	25.9	26.2	25.7
Dividend per share	2.20	0.88	0.88	0.90	0.90	0.98	1.00	1.00	3.50	1.00

Balance sheet

	FY2016	FY2017	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	80.5	96.2	88.4	68.3	75.2	85.6	94	81.6	67	34.6
Short-term investments							0	29.3	5.48	0
Receivables	37.4	35.7	40.4	43.1	37.9	39	53.5	47.2	37	38
Inventory	28	26.5	35.4	34.8	32.9	38.5	46.8	40	38.8	54.9
Other current assets	1.35	1.31	1.76
Total current assets	149	163	166	150	148	165	197	201	153	132
Property, plant and equipment	50	45.9	53.1	56.4	55.4	53.6	47.8	55	52.6	63.3
Lease right-of-use assets				20.1	19.2	15.5	13.1	9.83	9.83	9.5
Goodwill	70.6	70.6	81.6	82.5	88.6	88.7	91.8	94.3	94.3	107
Intangible assets	53.9	49.3	61.3	56.6	52.7	45.6	44.1	38.3	33.3	38.8
Other non-current assets	0.51	0.33	0.3	0.26	0.38	0.39	0.38	0.26	4.74	4.67
Total assets	324	329	363	366	364	369	394	399	349	357
Accounts payable	14.2	12.2	13.7	17.2	14.8	16.7	18.3	11.8	13.8	14.3
Accrued liabilities	13.5	17.4	17.9	15.1	15	15.4	18.1	17.5	15.3	16.8
Total current liabilities	30	29.6	31.6	38	35.1	37.2	41.2	33.8	33.3	35.4
Long-term debt	30	30	30
Lease liabilities				14.2	13.6	10.2	8.16	5.16	5.31	4.97
Other non-current liabilities	1.16	1.24	1.44	1.52	1.24	0.46	1.25	1.08	0.5	0.52
Total liabilities	72.9	67.7	74	71.4	63.8	65	62.4	49.3	47	48.2
Total debt	30	30	30
Paid-in capital	122	121	123	123	123	124	126	126	125	127
Retained earnings	151	164	179	194	194	198	219	236	184	201
Treasury stock	-80.7	-82.5	-71.4	-72.5	-71.8	-74.7	-74.9	-74.7	-71.6	-85.1
Other comprehensive income	-15.3	-16.4	-16.7		-20.3
Shareholders' equity	251	262	289	294	301	304	331	350	302	309
Total equity	251	262	289	294	301	304	331	350	302	309
Total liabilities and equity	324	329	363	366	364	369	394	399	349	357
Shares outstanding								30.1	30.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	1.78	32.9	37.4	38.3	24.1	29	47.3	42.6	40.2	42.6
Depreciation and amortization	7.93	8.03	9.07	10.4	9.92	10.4	10.2	9.86	8.84	9.05
Stock-based compensation	1.36	1.34	1.4	1.37	1.24	2.8	2.79	1.17	3.98	2.51
Deferred income tax	0.82	-1.79	-0.74	0.48	-2.71	3.16	-1.8	-1.65	-1.7	-1.22
Change in receivables	3.32	-0.02	1.48	1.78	6.12	-1.04	-9.25	8.87	9.49	1.09
Change in inventory	1.43	1.57	-3.58	3.24	3.19	-4.4	-7.78	9.12	3.07	-12.8
Change in payables	-0.14	-0.85	-2.38	-2.61	-3.34	1.53	3.33	-8.6	-0.88	1.12
Cash from operations	58.9	45.3	51.3	57.2	52.8	50.7	46.8	69.1	65.9	52.7
Capital expenditures	-3.07	-2.67	-4.82	-3.39	-3.68	-6.54	-4.33	-6.5	-5.89	-11.7
Acquisitions	-18.6	-1.35	-27.4	-18.7	-19.2	-4.34	-8.77	-19.6	-6.19	-38.9
Purchases of investments						0	0	-31.4	-10.1	0
Cash from investing	86.1	-3.95	-31.8	-21.4	-21.2	-10.1	-11.5	-55	13.2	-44.8
Debt repaid	-10			-30	0	0
Stock issued	2.91		0.07				0	0	0.17	0.04
Share buybacks	-8.44	-3.31	-4.81	-2.47	-1.24	-4.79	-1.12	-0.59	-1.84	-14.5
Dividends paid	-57.2	-22.3	-22.6	-23.5	-23.5	-25.4	-25.8	-25.9	-92	-25.9
Cash from financing	-72.5	-25.6	-27.4	-56	-24.7	-30.2	-27	-26.4	-93.7	-40.3
Net change in cash	72.5	15.8	-7.79	-20.2	6.93	10.4	8.36	-12.4	-14.6	-32.4
Free cash flow	55.8	42.6	46.5	53.8	49.1	44.1	42.4	62.6	60	41
Interest paid	0.85	0.73	1.11	0.72	0.01	0.06	0	0	0
Income taxes paid	0.98	15.5	9.87	14.5	9.5	11.6	18	19.2	16.4	16.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $22.13 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	30.8%	Gross profit / revenue.
Operating margin	13.5%	Operating income / revenue.
EBITDA margin	15.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.9%	Pre-tax income / revenue.
Net margin	10.8%	Net income / revenue.
FCF margin	14.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.8%	Cash from operations / revenue.
Effective tax rate	27.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.7%	Net income / average total assets.
Return on invested capital (ROIC)	14.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	2.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-7.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	8.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	1.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-6.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	6.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	6.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-3.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	12.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	7.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-3.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	12.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-19.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-31.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-1.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-3.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-71.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	2.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	2.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-2.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.53x	Current assets / current liabilities.
Quick ratio	2.06x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.21x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	14.5%	Total liabilities / total assets.
Working capital	$102.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	39.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$167.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.08x	Revenue / average total assets.
Fixed asset turnover	6.40x	Revenue / average property, plant and equipment.
Inventory turnover	4.86x	Cost of revenue / average inventory.
Days inventory	75 days	365 x average inventory / cost of revenue.
Receivables turnover	11.3x	Revenue / average receivables.
Days sales outstanding	32 days	365 x average receivables / revenue.
Days payables	20 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	87 days	Days inventory + days sales outstanding - days payables.
FCF conversion	129.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.67	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$15.43	Revenue / diluted weighted shares.
FCF per share	$2.17	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.59	Cash from operations / diluted weighted shares.
Book value per share	$12.17	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.56	Tangible book value / shares outstanding.
Cash per share	$1.92	(Cash + short-term investments) / shares outstanding.
Payout ratio	60.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	46.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	17.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$559.9M	Share price x shares outstanding.
Enterprise value	$510.8M	Market cap + total debt - cash - short-term investments.
P/E	13.1x	Market cap / net income. Only when net income is positive.
P/S	1.42x	Market cap / revenue.
P/B	1.80x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.35x	Market cap / tangible book value, when positive.
P/FCF	10.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.48x	Market cap / cash from operations, when positive.
EV/Sales	1.30x	Enterprise value / revenue.
EV/EBIT	9.64x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.24x	Enterprise value / EBITDA, when both are positive.
EV/FCF	9.23x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.9%	Free cash flow / market cap.
Earnings yield	7.6%	Net income / market cap (the inverse of P/E).
Dividend yield	4.6%	Dividends paid over the period / market cap.
Shareholder yield	6.3%	(Dividends paid + share buybacks) / market cap.

What was ENNIS, INC.'s revenue in fiscal 2026?

ENNIS, INC. reported revenue of $392.4M for fiscal 2026, 0.6% lower than the year before.

Was ENNIS, INC. profitable in fiscal 2026?

Yes. Net income was $42.6M, a net margin of 10.9%.

How much free cash flow did ENNIS, INC. generate in fiscal 2026?

Cash from operations of $52.7M minus capital expenditures of $11.7M left free cash flow of $41.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ENNIS, INC.